Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Paul Richardson, Ph.D. received his BA in biology and chemistry from Middlebury College in Vermont. His graduate work focused on transcriptional activation by oncogenes in an avian retroviral model system. He received his Ph. D. in Molecular Biology from Boston University in 1991. Paul performed postdoctoral work at Children's Hospital and Harvard Medical School in Boston in Dr. Leonard Zon's laboratory. While there, he studied gene activation through the use of subtractive hybridization. After working for two small start-up biotech genomic companies in Boston, Paul joined the Whitehead Institute/MIT Genome Center as the production sequencing manager. There, he managed the high-throughput sequencing facility during the initial scale-up for the Human Genome Project before moving to the Department of Energy's Joint Genome Institute, also involved in sequencing the human genome. Paul has led a group devoted to improving sequencing technology since joining the JGI in 1998. He is currently the head of the Genomic Technologies Program at the JGI, where he continues to develop new technologies for sequencing and functional genomics, and he serves as the JGI Microbial Program Lead.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »